# University Malaya Medical Centre

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-malaya-medical-centre/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 38.4 |
| Citations | 361,530 |
| City | Kuala Lumpur |
| Country | MY |
| Description | University Malaya Medical Centre is a research organisation in Kuala Lumpur, MY. OpenAlex records 8,487 works and 361,530 citations for it. 2,348 researchers list it as their most recent affiliation. |
| Homepage | http://www.ummc.edu.my/# |
| OpenAlex ID | https://openalex.org/I1296788130 |
| Researchers | 2,348 |
| ROR ID | https://ror.org/00vkrxq08 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q7894810 |
| Works | 8,487 |

## University papers

Showing 12 of 38.

- [Definition and diagnostic criteria of clinical obesity](https://scholariq.org/papers/definition-and-diagnostic-criteria-of-clinical-obesity/)
- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial](https://scholariq.org/papers/effects-of-the-sglt2-inhibitor-dapagliflozin-on-proteinuria-in-non-diabetic/)
- [Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO](https://scholariq.org/papers/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-management-of-2/)
- [Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine](https://scholariq.org/papers/second-international-consensus-report-on-gaps-and-opportunities-for-the-clinical/)
- [Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial](https://scholariq.org/papers/pembrolizumab-versus-placebo-as-second-line-therapy-in-patients-from-asia-with/)
- [Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)](https://scholariq.org/papers/espindolol-for-the-treatment-and-prevention-of-cachexia-in-patients-with-stage/)
- [Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice](https://scholariq.org/papers/insights-from-credence-trial-indicate-an-acute-drop-in-estimated-glomerular/)
- [Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline](https://scholariq.org/papers/treatment-of-patients-with-early-stage-colorectal-cancer-asco-resource/)
- [Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease](https://scholariq.org/papers/effect-of-sglt2-inhibitors-on-stroke-and-atrial-fibrillation-in-diabetic-kidney/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial](https://scholariq.org/papers/pembrolizumab-monotherapy-versus-chemotherapy-in-platinum-pretreated-recurrent/)

## University researchers

- [Soo Kun Lim](https://scholariq.org/researchers/soo-kun-lim/)
- [Gwo Fuang Ho](https://scholariq.org/researchers/gwo-fuang-ho/)
- [Phaik‐Leng Cheah](https://scholariq.org/researchers/phaik-leng-cheah/)
- [Darwish Mohd Isa](https://scholariq.org/researchers/darwish-mohd-isa/)

## University top topics

Showing 8 of 25.

- [Mosquito-borne diseases and control](https://scholariq.org/topics/mosquito-borne-diseases-and-control/)
- [Viral Infections and Vectors](https://scholariq.org/topics/viral-infections-and-vectors/)
- [Malaria Research and Control](https://scholariq.org/topics/malaria-research-and-control/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [Burkholderia infections and melioidosis](https://scholariq.org/topics/burkholderia-infections-and-melioidosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.